ISS Recommends SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioTools
December 22, 2023 18:47 ET
|
SomaLogic
BOULDER, Colo., Dec. 22, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, today announced that Institutional Shareholder Services (“ISS”) has recommended that SomaLogic...
SomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioTools
December 21, 2023 08:00 ET
|
SomaLogic
Combination Builds Scale and Accelerates Path to Profitability, Unlocking Significant Potential Value for SomaLogic Stockholders Madryn’s Concerns are Not Based on Facts, and Madryn Selectively...
SomaLogic Reports Recent Business Highlights and Third Quarter 2023 Financial Results
November 08, 2023 16:05 ET
|
SomaLogic
Revenue of $22.0 million, reflecting 14% year-over-year growth when excluding royalty revenue from NEB in the corresponding prior-year periodCash and investments of over $450 millionRaising full year...
SomaLogic announces new SomaScan® 11K Platform
November 01, 2023 09:00 ET
|
SomaLogic
BOULDER, Colo., Nov. 01, 2023 (GLOBE NEWSWIRE) -- SomaLogic Inc., (Nasdaq:SLGC), a leader in data-driven proteomics technology, today announced the launch of its high-plex proteomics platform, which...
SomaLogic to Announce Third Quarter 2023 Financial Results on November 8, 2023
October 31, 2023 16:30 ET
|
SomaLogic
BOULDER, Colo., Oct. 31, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, today announced that it will report financial results for the third quarter 2023 after market...
SomaLogic and Korea’s DNA Link partner to bring the 7,000-plex SomaScan® platform to the fast-growing Asia-Pacific proteomics market
September 19, 2023 16:30 ET
|
SomaLogic
BOULDER, Colo. and SEOUL, Korea, Sept. 19, 2023 (GLOBE NEWSWIRE) -- SomaLogic Inc., (Nasdaq:SLGC), a leader in data-driven proteomics technology, today announced its partnership with DNA Link, an...
SomaLogic researchers identify key proteins to aid in early detection of lung, colon and breast cancer and ovarian tumors
September 12, 2023 09:00 ET
|
SomaLogic
BOULDER, Colo., Sept. 12, 2023 (GLOBE NEWSWIRE) -- In a new paper published in Nature's Scientific Reports, researchers at SomaLogic Inc. studied the value of protein biomarkers in the early...
SomaLogic expands agreement with Novo Nordisk to 2025
September 05, 2023 08:30 ET
|
SomaLogic
BOULDER, Colo., Sept. 05, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, announced today that it is extending its collaborative agreement with global healthcare...
SomaLogic Reports Second Quarter 2023 Financial Results
August 14, 2023 16:05 ET
|
SomaLogic
Revenue of $20.5 million, an increase of 45% year-over-yearCash and investments of approximately $474 million, a strong capital position to fund current and future business initiativesReiterating full...
SomaLogic to Announce Second Quarter 2023 Financial Results on August 14, 2023
July 24, 2023 16:30 ET
|
SomaLogic
BOULDER, Colo., July 24, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, today announced that it will report financial results for the second quarter 2023 after market...